---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-001581"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2024-01-18T23:59:59+00:00"
generated_at: "2026-06-06T21:50:01.278424+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Puma Biotechnology presents at B. Riley Oncology Conference; no material new information disclosed.

## Summary
- Presentation at B. Riley Securities 4th Annual Oncology Conference on January 18, 2024.
- Chairman, President and CEO Alan H. Auerbach to present.
- Exhibit 99.1 presentation not included as extractable text; specifics unavailable.
- No financial or operational updates disclosed in the filing.

## SEC filing metadata
- accession: 0001437749-24-001581
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2024-01-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774924001581/0001437749-24-001581-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774924001581/pbyi20240116_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-001581
- JSON: https://secwatch.observer/filing/0001437749-24-001581.json
- Plain text: https://secwatch.observer/filing/0001437749-24-001581.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.